← All stories
Tech
Ex-Legend CEO takes helm at biotech startup scouring the globe for drugs
Ying Huang is now running K2 Therapeutics, which has licensed multiple prospects from China-based biotechs and is searching for more “high-potential” medicines.
Covered by 1 outlet
All coverage · 1 article